sr 48692 has been researched along with pentagastrin in 1 studies
| Studies (sr 48692) | Trials (sr 48692) | Recent Studies (post-2010) (sr 48692) | Studies (pentagastrin) | Trials (pentagastrin) | Recent Studies (post-2010) (pentagastrin) |
|---|---|---|---|---|---|
| 203 | 3 | 36 | 3,639 | 207 | 51 |
| Protein | Taxonomy | sr 48692 (IC50) | pentagastrin (IC50) |
|---|---|---|---|
| Cholecystokinin receptor type A | Rattus norvegicus (Norway rat) | 0.8875 | |
| Gastrin/cholecystokinin type B receptor | Homo sapiens (human) | 0.001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karinch, AM; Kauffman, GL; Schmidt, GL | 1 |
1 other study(ies) available for sr 48692 and pentagastrin
| Article | Year |
|---|---|
Pretreatment with SR48692 has different effects on central neurotensin-induced gastric mucosal defense and inhibition of gastric acid secretion in rats.
Topics: Animals; Anti-Ulcer Agents; Cold Temperature; Gastric Acid; Gastric Mucosa; Injections, Intraperitoneal; Injections, Intraventricular; Male; Neurotensin; Pentagastrin; Pylorus; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Restraint, Physical; Stress, Psychological | 1998 |